Components

Case Study
Powerpoint

Moderna, Inc.: Protecting Against Corporate Espionage

Joe Gray, Katie Turner, Kevin Mather, James S. O’Rourke
January 15, 2023
SKU:
BUS-008896
Region: 
North America
Topic: 
Operations
Length: 
13 pages
Keywords: 
covid-19, vaccine, Moderna, Pfizer, BioNTech, Corporate Espionage, Proprietary Data
Student Price: 
$4.00 (€3.66)
Average rating: 
0

Moderna, Inc.: Protecting Against Corporate Espionage Gray, J.; Turner, K.; Mather, K.; O’Rourke, J. S. (editor) We live in a world where large corporations operate in a matrix of highly competitive markets. Companies in the private biotechnology and pharmaceutical industry have resorted to corporate espionage to gain a competitive advantage. Moderna, Inc., the creator of a highly successful COVID-19 vaccine, has accused competitors, including BioNTech and Pfizer of data attacks conducted as a form of corporate espionage. Executives at Moderna are now faced with maintaining a balance between protecting public health and safeguarding its own research.